secwatch.observer — SEC 8-K summary
======================================

Issuer:     MIRA PHARMACEUTICALS, INC. (MIRA)
CIK:        0001904286
Form:       8-K
Filed at:   2024-01-17T23:59:59+00:00
Accession:  0001493152-24-002729
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director and part-time General Counsel Christos Nicholoudis resigns
-------------------------------------------------------------------

- Christos Nicholoudis resigned from the Board and as part-time General Counsel effective January 15, 2024.
- Resignation did not involve disagreements with the Company, management, or Board.
- No replacement for the director or General Counsel role announced in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1904286/000149315224002729/0001493152-24-002729-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1904286/000149315224002729/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-002729

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer